Canaccord Genuity Starts Gemphire Therapeutics (GEMP) at Buy

August 30, 2016 6:40 AM EDT
Get Alerts GEMP Hot Sheet
Price: $10.00 --0%

Rating Summary:
    3 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade GEMP Now!
Join SI Premium – FREE

Get the Pulse of the Market with StreetInsider.com's Pulse Picks. Get your Free Trial here.

Canaccord Genuity initiated coverage on Gemphire Therapeutics (NASDAQ: GEMP) with a Buy rating and a price target of $17.00.

For an analyst ratings summary and ratings history on Gemphire Therapeutics click here. For more ratings news on Gemphire Therapeutics click here.

Shares of Gemphire Therapeutics closed at $10.15 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

New Coverage

Related Entities

Canaccord Genuity

Add Your Comment